UPDATE: Deutsche Bank Upgrades IPC The Hospitalist Company to Buy on Good Growth Prospects
April 25, 2013 at 10:38 AM EDT
In a report published Thursday, Deutsche Bank analyst Darren Lehrich upgraded the rating on IPC The Hospitalist Company (NASDAQ: IPCM ) from Hold to Buy, and raised the price target from $36.00 to $48.00. In the report, Lehrich noted, “IPCM continues to churn out strong growth, and the valuation multiples
